The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies
- 25 August 2012
- journal article
- review article
- Published by S. Karger AG in Dermatology
- Vol. 225 (1), 45-53
- https://doi.org/10.1159/000339865
Abstract
Economic evaluation is an increasingly important aspect of assessment of the burden of skin diseases. Although dermatology data were not used in its development, the use of the EQ-5D questionnaire has been encouraged by the requirement of health technology assessment agencies for utility comparisons informing reimbursement decisions. The aim of this review was to examine the use of the EQ-5D in dermatology and to consider its future role in the economic evaluation of skin diseases. Published studies reporting the use of the EQ-5D in the economic analysis of skin diseases were carefully examined. Nineteen articles and 1 abstract published between 2003 and 2011 were identified, in which cost-of-illness, cost-effectiveness and cost-utility analyses were described. The EQ-5D is not a dermatology-specific measure, and it is not yet clear whether it is the most appropriate measure to support economic evaluation in the context of dermatology.Keywords
This publication has 28 references indexed in Scilit:
- Measuring herpes zoster, zoster‐associated pain, post‐herpetic neuralgia‐associated loss of quality of life, and healthcare utilization and costs in ThailandInternational Journal of Dermatology, 2011
- Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema - a long-term analysis from a Swiss perspectiveBMC Dermatology, 2010
- Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study)BMJ, 2010
- Burden of skin diseasesExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- What is ‘quality of life’ for patients?British Journal of Healthcare Management, 2008
- Patient preference quality of life measures in dermatologyDermatologic Therapy, 2007
- Patient perspectives on the management of atopic dermatitisJournal of Allergy and Clinical Immunology, 2006
- The burden of Herpes Zoster: A prospective population based studyVaccine, 2006
- Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United StatesJournal of the American Academy of Dermatology, 2005
- Quality of life measurement in dermatology: a practical guideBritish Journal of Dermatology, 1997